Fontana, M., Gillmore, J. D., Witteles, R. M., Laryea, B., Dworkin, M., Payne, A., Kochman, F., Eraly, S., & Maurer, M. S. (2025). Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary. Future Cardiology, 1–11. https://doi.org/10.1080/14796678.2025.2493019

Ojha, U., Parikh, M., & Patel, V. (2023). Percutaneous Approach for Reducing Outflow Tract Obstruction in Hypertrophic Obstructive Cardiomyopathy. Future Cardiology, 19(4), 203–210. https://doi.org/10.2217/fca-2022-0098

Sharma, N., Finn, M. T., Parikh, S. A., & Granada, J. (2023). The Ranger Drug-Coated Balloon: Advances in Drug-Coated Technology for Treatment of Femoropopliteal Segment Arterial Disease. Future Cardiology, 19(3), 127–135. https://doi.org/10.2217/fca-2022-0072

Hanna, M., Damy, T., Grogan, M., Stewart, M., Gundapaneni, B., Sultan, M. B., & Maurer, M. S. (2021). Tafamidis and Quality of Life in People With Transthyretin Amyloid Cardiomyopathy in the Study ATTR-ACT: A Plain Language Summary. Future Cardiology, 18(3), 165–172. https://doi.org/10.2217/fca-2021-0095